Published in J Travel Med on February 10, 2004
Travel patterns and risk behaviour of HIV-positive people travelling internationally. CMAJ (2005) 1.07
Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures. Ther Clin Risk Manag (2015) 0.77
Immunizations for renal transplant candidates and recipients. Nat Clin Pract Nephrol (2008) 0.75
Identification of severe acute respiratory syndrome in Canada. N Engl J Med (2003) 14.29
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation (2010) 4.00
Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis (2006) 3.69
Illness after international travel. N Engl J Med (2002) 3.56
Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis (2007) 3.53
Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis (2002) 3.13
West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03
Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers. Am J Trop Med Hyg (2003) 2.75
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2009) 2.66
Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med (2011) 2.59
Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg (2002) 2.55
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation (2013) 2.43
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol (2007) 2.35
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Malaria. CMAJ (2004) 2.13
Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg (2003) 2.12
Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation (2004) 2.11
Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ (2004) 2.11
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen. J Clin Microbiol (2003) 2.08
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis (2010) 1.98
Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. Lancet (2003) 1.98
Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study*. Crit Care Med (2012) 1.97
RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med (2010) 1.94
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
Evaluation of the RealArt Malaria LC real-time PCR assay for malaria diagnosis. J Clin Microbiol (2004) 1.91
Advances in malaria diagnosis. Expert Rev Anti Infect Ther (2007) 1.84
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA (2003) 1.81
Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis (2004) 1.80
Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers. Clin Infect Dis (2006) 1.79
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Furuncular myiasis: a simple and rapid method for extraction of intact Dermatobia hominis larvae. Clin Infect Dis (2002) 1.73
Molecular diagnostic and surveillance tools for global malaria control. Travel Med Infect Dis (2007) 1.73
Pyruvate kinase deficiency and malaria. N Engl J Med (2008) 1.72
Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis (2008) 1.64
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis (2009) 1.64
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J (2009) 1.59
Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria. Cell Host Microbe (2013) 1.57
A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy. J Infect Dis (2007) 1.56
Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med (2002) 1.55
Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One (2011) 1.55
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med (2007) 1.49
Tropical pulmonary eosinophilia: a case series in a setting of nonendemicity. Clin Infect Dis (2004) 1.45
Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant (2005) 1.45
Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One (2010) 1.43
Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa. Clin Infect Dis (2003) 1.40
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med (2008) 1.38
Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis (2002) 1.37
CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages. J Infect Dis (2004) 1.36
A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation (2010) 1.35
Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa. Am J Trop Med Hyg (2005) 1.33
Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II). Am J Trop Med Hyg (2007) 1.32
Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog (2008) 1.28
The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. AIDS (2010) 1.25
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis (2012) 1.25
Leprosy in Toronto: an analysis of 184 imported cases. CMAJ (2004) 1.24
Convergence of quantum dot barcodes with microfluidics and signal processing for multiplexed high-throughput infectious disease diagnostics. Nano Lett (2007) 1.22
Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria. BMC Genomics (2006) 1.20
Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria. Am J Pathol (2007) 1.20
Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis (2004) 1.18
Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J Immunol (2007) 1.18
Leprosy: a primer for Canadian physicians. CMAJ (2004) 1.17
CD36 and malaria: friends or foes? Trends Parasitol (2003) 1.16
C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. PLoS One (2009) 1.16
Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis (2004) 1.16
Regional variation in travel-related illness acquired in Africa, March 1997-May 2011. Emerg Infect Dis (2014) 1.15
Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India. J Clin Microbiol (2007) 1.15
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14
Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya. Am J Trop Med Hyg (2009) 1.12
Mechanism of protection induced by vitamin A in falciparum malaria. Lancet (2002) 1.11
Lack of evidence for chloroquine-resistant Plasmodium falciparum malaria, Leogane, Haiti. Emerg Infect Dis (2012) 1.11
State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician. Clin Infect Dis (2012) 1.10
Prospective analysis of parasitic infections in Canadian travelers and immigrants. J Travel Med (2006) 1.09
CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum. Infect Immun (2003) 1.09
Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09
A seroprevalence study of west nile virus infection in solid organ transplant recipients. Am J Transplant (2004) 1.09
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08
Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biomarkers Prev (2009) 1.07
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation (2011) 1.07
Tafenoquine: a promising new antimalarial agent. Expert Opin Investig Drugs (2007) 1.07
Travel patterns and risk behaviour of HIV-positive people travelling internationally. CMAJ (2005) 1.07
Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials (2011) 1.06
Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation (2005) 1.05
A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis (2005) 1.05
Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria. Expert Rev Anti Infect Ther (2011) 1.05
CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria. J Immunol (2009) 1.05
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther (2009) 1.05
A review of amoebic liver abscess for clinicians in a nonendemic setting. Can J Gastroenterol (2012) 1.04
Complement driven innate immune response to malaria: fuelling severe malarial diseases. Cell Microbiol (2010) 1.04
Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization. Dev Cell (2013) 1.04
Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One (2011) 1.03
Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria. J Infect Dis (2009) 1.03
Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer (2005) 1.02
Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02
Cost-effectiveness of screening for anal precancers in HIV-positive men. AIDS (2011) 1.02
S1P is associated with protection in human and experimental cerebral malaria. Mol Med (2011) 1.02
Serial nosocomial transmission of Plasmodium falciparum malaria from patient to nurse to patient. Infect Control Hosp Epidemiol (2004) 1.02
Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study. BMC Med Res Methodol (2013) 1.01
Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. Transplantation (2012) 1.00